Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Filings indexed 2,883 across all filing types
Latest filing 2025-08-14 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
关于首次回购公司股份的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from a company about its first share repurchase (buyback) activity. It details the number of shares repurchased, prices, total amount spent, and compliance with regulatory rules. The text does not contain financial statements or detailed financial analysis but focuses on the share repurchase event and regulatory compliance disclosures. The document length is short (1236 characters) and it is clearly an announcement of a share buyback event, not a full financial report or earnings release. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2025-08-14 Chinese
关于控股子公司2025年度第一期超短期融资券发行结果公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the issuance results of a short-term financing bond by a controlling subsidiary of the company. It includes details such as issuance amount, interest rate, dates, and registration information. There is no indication of a full financial report or detailed financial statements. The document is focused on capital raising activity and financing details. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is short and it is not merely announcing the publication of a report but providing issuance results, so it is not a Report Publication Announcement (RPA).
2025-08-07 Chinese
关于回购股份用于注销并减少注册资本暨通知债权人的公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement by Chongqing Pharmaceutical Holdings Co., Ltd. regarding the repurchase of shares to be cancelled and the consequent reduction of registered capital. It includes details about the repurchase plan, the amount, price limits, and the legal rights of creditors to claim debts or request guarantees within 45 days. The document is a formal notification to creditors and shareholders about the share repurchase and capital reduction, not a financial report or detailed analysis. It is an announcement related to the company's capital structure changes, specifically about share repurchase and capital reduction. According to the filing definitions, announcements about share repurchase or capital changes fall under the category 'Transaction in Own Shares (POS)' or 'Share Issue/Capital Change (SHA)'. Since this is about repurchasing shares for cancellation and capital reduction, it fits best under 'Transaction in Own Shares (POS)'. The document length is short (1267 characters), and it is not a report but an announcement, so it is not a full financial report. Therefore, the correct classification is POS with high confidence.
2025-08-06 Chinese
关于聘任副总经理的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the appointment of a new deputy general manager (副总经理) at the company 重药控股股份有限公司. It includes details about the appointment decision by the board, the nominee's background, and compliance with relevant laws and regulations. There is no financial data, no mention of financial results, no shareholder voting results, no legal proceedings, and no mention of report publication. The content clearly relates to management changes. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on management appointment, confirming this classification with high confidence.
2025-08-05 Chinese
关于回购股份进展的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from a company about the progress of its share repurchase program. It details the board and shareholder approvals for the buyback, the amount and price limits, and states that as of the end of July 2025, no shares have been repurchased yet. The document is short (740 characters) and focuses on the status update of the share buyback, not on financial results or other report types. This fits the definition of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back or selling its own shares.
2025-08-05 Chinese
第九届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 16th meeting of the 9th Board of Directors of the company. It includes details about the meeting date, attendance, and the approval of the appointment of a deputy general manager. It references a related announcement about the appointment. The content focuses on board decisions and management changes rather than financial results or reports. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report itself but an announcement of board decisions.
2025-08-05 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.